Document is current
Any future updates will be listed below
-
Authors
Kato, Atsushi https://orcid.org/0000-0001-9144-3138
Kita, Hirohito https://orcid.org/0000-0002-6854-2936
- License Information
-
More Information
Article History
Accepted: 4 March 2025
First Online: 16 April 2025
Competing interests
: A.K. has served on an advisory board for AstraZeneca. A.K. has received research grants from Regeneron Pharmaceuticals and AstraZeneca. H.K. received a royalty from Aiolos Bio and GlaxoSmithKline.
